Split Personality: How a Divided Congress May Hit Banks, Tech & Pharma

The video discusses the potential impacts of political changes on various sectors, including pharmaceuticals, biotech, banks, tech, and industrials. It highlights how gridlock or a Democratic sweep in Congress could affect these industries, with specific focus on price controls, regulation, and trade wars. The analysis includes insights from Bloomberg Terminal data and expert opinions.

What political event could potentially benefit large cap biotech and pharma stocks?

• Increased interest rates

• A new trade agreement

• A Republican sweep of Congress

• Gridlock in the House

Which companies were mentioned as potentially taking a hit due to political actions?

• Johnson & Johnson and Novartis

• Roche and Sanofi

• Biogen and Amgen

• Pfizer and Merck

What is the expected impact on banks if the Democrats take the House?

• Higher interest rates

• No significant harm

• Increased regulations

• More mergers and acquisitions

What ongoing issues are affecting the technology sector?

• Election hacking and social media issues

• Rising oil prices

• Increased competition from Asia

• New environmental regulations

What is the likelihood of an infrastructure spending package according to Goldman Sachs?

• 50%

• 75%

• 90%

• 25%